TransMedics (TMDX) Operating Income Growth (3y) (2021 - 2026)
TransMedics (TMDX) Operating Income Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 34.83% |
| 10 | TransMedics | 2.53 Bn | 2.07 Bn | 101.16 Mn | 103.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.00% |
| Dec 31, 2025 | 72.56% |
| Sep 30, 2025 | 83.74% |
| Jun 30, 2025 | 79.18% |
| Mar 31, 2025 | 70.19% |
| Dec 31, 2024 | 40.32% |
| Sep 30, 2024 | 32.66% |
| Jun 30, 2024 | 48.39% |
| Mar 31, 2024 | 57.53% |
| Dec 31, 2023 | 34.65% |
| Sep 30, 2023 | -83.18% |
| Jun 30, 2023 | 51.33% |
| Mar 31, 2023 | 36.13% |
| Dec 31, 2022 | 7.96% |
| Sep 30, 2022 | 8.52% |
| Jun 30, 2022 | -8.14% |
| Mar 31, 2022 | -16.26% |
| Dec 31, 2021 | -21.21% |
| Sep 30, 2021 | -43.85% |
| Jun 30, 2021 | -24.16% |